Position in ANNX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,893,505
-$1,358,524 QoQ
Shares Held
702,799
-32.8% QoQ
Ownership
0.352%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
10 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Derivatives in ANNX
reported options exposure · as of Jun 30, 2024CallValue
$0
CallShares
0
PutValue
$98,000
PutShares
20,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026D. E. Shaw & Co., Inc. holds $4,371,472,260 across 180 Biotechnology names. ANNX ranks #97 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,625,825 | $919,934,903 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,059,062 | $350,411,843 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
2,545,486 | $189,027,789 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
2,865,318 | $166,503,628 | |
| 5 | EXEL |
Exelixis, Inc.
|
3,603,063 | $154,535,371 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
1,868,708 | $120,774,597 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
1,640,381 | $111,759,157 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
248,960 | $111,170,598 |
All Filings in ANNX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,893,505 | 702,799 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,252,029 | 1,046,221 | Shares | Defined | 2026-02-17 | |
| 2024-09-30 | $481,953 | 81,411 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $98,000 | 20,000 | Put | Defined | 2024-08-14 | |
| 2024-06-30 | $451,216 | 92,085 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,719,251 | 379,254 | Shares | Defined | 2024-05-15 | |
| 2023-03-31 | $104,473 | 27,136 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $405,891 | 78,509 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $296,794 | 48,025 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $144,489 | 38,326 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $446,024 | 163,379 | Shares | Defined | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||